Patients were then randomly selected to receive either 0.05% (dilute) proparacaine or placebo eye drops as outpatient and followed up by a specific ophthalmologist.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Analysts noted that despite delivering a solid financial performance led by a sharp uptick in deal wins, both TCS and HCL Tech faced pressure due to higher expectations on the Street. India's ...

HCL Tech Q3 Results: IT services company HCL Technologies on Monday reported 6% growth in its consolidated net profit at Rs 4,591 crore for the quarter ended December 2024. The same stood at Rs 4,350 ...

30 days Prescribing information Latanoprost 0.005% ophthalmic solution Xalatan (Pharmacia and Upjohn) 6 wk Prescribing information Lopinavir/ritonavir capsules Kaletra capsules (Abbott ...

HCL Technologies shares dropped 9.23% after the company reported a 6% net profit growth for Q3 at Rs 4,591 crore. Revenue rose to Rs 29,890 crore. New deal bookings reached $2.1 billion. Analysts ...

C2 PHARMA, the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), announces the approval of a Certificate of Suitability (CEP) for ...

23 Oct, 2019 05 Dec, 2019 1:1 For every 1 share held; Holder will receive 1 bonus shares. 30 Jan, 2015 19 Mar, 2015 1:1 For every 1 share held; Holder will receive 1 bonus shares. 14 Dec, 2006 15 ...

HCL Tech, one of the largest tech companies in the country, got off to an abysmal start in the equity market on Tuesday, as the shares collapsed by over 9 per cent in the very first hour of the ...

Financial services companies Anand Rathi Wealth Ltd. and Angel One Ltd. are among the key companies set to release their Q3 earnings on Monday. Delta Corp Ltd. and IT major HCL Technologies Ltd. are ...